Orange Book product · Generic (ANDA)
BETAMETHASONE DIPROPIONATE
BETAMETHASONE DIPROPIONATE
At a glance
Dec 18, 2019
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 18, 2019
6 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
BETAMETHASONE DIPROPIONATE
Strength
EQ 0.05% BASE
Dosage form
OINTMENT, AUGMENTED
Route
TOPICAL
TE code
AB
Application
ANDA 209106
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BETAMETHASONE DIPROPIONATE
- 1988DIPROLENEBrand (NDA)
NDA 019716 · ORGANON
- 1987DIPROLENE AFBrand (NDA)
NDA 019555 · ORGANON
- 1986DIPROLENEBrand (NDA)
NDA 019408 · SCHERING
- 1984ALPHATREXBrand (NDA)
NDA 019143 · SAVAGE LABS
- 1984BETAMETHASONE DIPROPIONATEBrand (NDA)
NDA 019141 · FOUGERA PHARMS INC
- 1984ALPHATREXBrand (NDA)
NDA 019138 · SAVAGE LABS
- 1984BETAMETHASONE DIPROPIONATEBrand (NDA)
NDA 019137 · FOUGERA PHARMS
- 1984BETAMETHASONE DIPROPIONATEBrand (NDA)
NDA 019136 · PHARMADERM
- 1983DIPROLENEBrand (NDA)
NDA 018741 · ORGANON
- —DIPROSONEBrand (NDA)
NDA 017536 · SCHERING
- —DIPROSONEBrand (NDA)
NDA 017829 · SCHERING
- —DIPROSONEBrand (NDA)
NDA 017781 · SCHERING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
